Trial · NCT00208975
Adverse events23
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 23
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Neutropenia | Blood and lymphatic system disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 10 | 15 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 7 | 15 | |
| other | Anemia | Blood and lymphatic system disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 9 | 15 | |
| other | Nausea | Gastrointestinal disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 9 | 15 | |
| other | Fatigue | General disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 7 | 15 | |
| other | Vomiting | Gastrointestinal disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 3 | 15 | |
| other | Arthritis | Musculoskeletal and connective tissue disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 2 | 15 | |
| other | Diarrhea | Gastrointestinal disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 1 | 15 | |
| other | Fever | General disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 3 | 15 | |
| other | Night Sweats | General disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 4 | 15 | |
| other | Hyperkalemia | Renal and urinary disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 1 | 15 | |
| other | Pain | General disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 12 | 15 | |
| other | Constipation | Gastrointestinal disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 5 | 15 | |
| other | Infusion reaction | Skin and subcutaneous tissue disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 4 | 15 | |
| other | Hypoprotinemia | Blood and lymphatic system disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 1 | 15 | |
| other | Weight Loss | General disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 2 | 15 | |
| other | Loss of Appetite | General disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 4 | 15 | |
| other | Anxiety | General disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 2 | 15 | |
| other | Muscositis | Gastrointestinal disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 3 | 15 | |
| other | Polyuria | Renal and urinary disorders | Fludarabine and Cyclophosphamide With Sequential Administratio | 2 | 15 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00208975/events